TrialThe New England journal of medicine2025
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
Jedd D Wolchok et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
370 papers cite itlatest 60 shown
this paperpooled ittrialcites it